Detecting early stages of Alzheimer’s disease using a web-based cognitive battery
GeroScience · 2024
DOI: 10.1007/s11357-024-01496-3 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift GeroScience, 2024. Verfasst von Jordan R Hoffmeister und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Sciences, The University of Oklahoma Health Science Center, Oklahoma City, OK, USA. jordanhoffmeister@gmail.c…. Hauptthemen laut MEDLINE: Alzheimer Disease, Neuropsychological Tests, Cognitive Dysfunction, Internet. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CSRD VA, U.S. Department of Veterans Affairs, Alzheimer's Drug Discovery Foundation.
Themen: Demenz
Abstract (Originalsprache)
Portable and efficient cognitive screening measures are needed to address the growing need for effective early detection of Alzheimer's disease. The Neurotrack Cognitive Battery (NCB) offers an appealing, web-based application that may be sensitive to early cognitive changes associated with Alzheimer's disease. The NCB contains measures that were conceptually derived from animal lesion studies. The current study sought to investigate the construct and diagnostic validity of the NCB among those with and without mild cognitive impairment (MCI). Participants (n = 47) with and without MCI were administered the NCB and traditional cognitive tests. Three of six NCB measures assessing domains of memory, processing speed, and executive functioning demonstrated moderate to strong associations with well-established cognitive performance tests. In classifying those with and without MCI, sensitivities of these three NCB measures ranged from 0.47 to 0.74, and specificities ranged from 0.78 to 1.00. For traditional cognitive measures, sensitivities ranged from 0.74 to 0.84, and specificities ranged from 0.74 to 0.94. Overall, web-based cognitive test measures pertaining to cognitive domains of memory, processing speed, and executive functioning may serve as highly portable screening tools for detecting the early stages of Alzheimer's disease. Additionally, these cognitive domains may be valuable in informing back-translational research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry and Behavioral Sciences, The University of Oklahoma Health Science Center, Oklahoma City, OK, USA. jordanhoffmeister@gmail.com.
- Department of Psychiatry and Behavioral Sciences, The University of Oklahoma Health Science Center, Oklahoma City, OK, USA.
- Department of Neurology, The University of Oklahoma Health Science Center, Oklahoma City, OK, USA.
- Oklahoma City VA Medical Center, Oklahoma City, OK, USA.
- Neurotrack Technologies, Inc., Redwood City, CA, USA.
ORCID-Profile: Jordan R Hoffmeister
Förderung
- CSRD VA
- U.S. Department of Veterans Affairs
- Alzheimer's Drug Discovery Foundation
Zitieren
APA
Hoffmeister, J. R., Robison, B. R., Copeland, C. T., Prodan, C. I., Scott, J. G., & Glenn, J. M. (2024). Detecting early stages of Alzheimer’s disease using a web-based cognitive battery. GeroScience. https://doi.org/10.1007/s11357-024-01496-3
Vancouver
Hoffmeister JR, Robison BR, Copeland CT, Prodan CI, Scott JG, Glenn JM. Detecting early stages of Alzheimer’s disease using a web-based cognitive battery. GeroScience. 2024. doi:10.1007/s11357-024-01496-3
BibTeX
@article{Hoffmeister2024,
author = {Hoffmeister, Jordan R and Robison, Brady R and Copeland, Christopher T and Prodan, Calin I and Scott, Jim G and Glenn, Jordan M},
title = {Detecting early stages of Alzheimer’s disease using a web-based cognitive battery},
journal = {GeroScience},
year = {2024},
doi = {10.1007/s11357-024-01496-3}
}
EUVIMED